Nom du produit:N1-(7-Cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-N3,N3,2,2-tetramethylpropane-1,3-diamine

IUPAC Name:7-cyclobutyl-N-[3-(dimethylamino)-2,2-dimethylpropyl]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-amine

CAS:473382-39-7
Formule moléculaire:C22H30N6
Pureté:97%
Numéro de catalogue:CM164558
Poids moléculaire:378.52

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:473382-39-7
Formule moléculaire:C22H30N6
Point de fusion:-
Code SMILES:CC(CN(C)C)(C)CNC1=NN2C(C=C1C3CCC3)=NN=C2C4=CC=CC=C4
Densité:
Numéro de catalogue:CM164558
Poids moléculaire:378.52
Point d'ébullition:
N° Mdl:MFCD16038643
Stockage:

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Related Products